Form 4: Hims & Hers CFO Oluyemi Okupe Executes Stock Option and Sells Shares Under 10b5-1 Plan

Hims & Hers Chief Financial Officer, Oluyemi Okupe, exercised stock options and sold shares of Class A Common Stock on November 25, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., executed a series of transactions involving the company's Class A Common Stock on November 25, 2024.
• These transactions included the exercise of stock options to acquire 97,776 shares at a price of $5.01 per share.
• Following the option exercise, Mr. Okupe sold a total of 101,993 shares of Class A Common Stock in multiple transactions at prices ranging from $26.52 to $30.13 per share.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• After these transactions, Mr. Okupe directly owns 109,392 shares of Class A Common Stock, which includes 1,423 shares acquired through the Employee Stock Purchase Plan on November 20, 2024.
• Mr. Okupe also holds 439,048 stock options.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions under a pre-arranged plan. While the sale of shares might cause some concern, the use of a 10b5-1 plan mitigates negative sentiment. The sentiment is neutral to slightly positive.

Positives

• The stock option exercise demonstrates the CFO's belief in the company's long-term value.
• The sales were conducted under a pre-arranged 10b5-1 plan, which is a common practice for executives to avoid insider trading concerns.

Negatives

• The sale of a significant number of shares by the CFO could be perceived negatively by some investors, although it is part of a pre-planned strategy.

Risks

• The market may react negatively to the CFO selling a large number of shares, even if it is part of a pre-planned strategy.
• Fluctuations in the stock price could impact the value of the remaining shares and options held by the CFO.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the broader telehealth industry.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies, including those in the telehealth sector.
• The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, and many executives at comparable companies such as Teladoc Health and Amwell also utilize these plans.
• The vesting schedule of the options is typical for executive compensation packages.

Stakeholder Impact

• Shareholders may react to the sale of shares by the CFO, but the pre-planned nature of the transactions should mitigate concerns.
• Employees may see the stock option exercise as a positive sign of the company's value.

Key Dates

Keywords

Form 4, insider trading, stock options, Rule 10b5-1, share sales, Hims & Hers, Oluyemi Okupe, CFO, equity securities